Launch Tech Co Ltd Stock
Price
Target price
?
?
2.680%
0.02
2.680%
-
08:33 / Stuttgart Stock Exchange
WKN: A0M4VZ / Name: Launch / Stock / Machinery, Equipment & Components / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Launch Tech Co Ltd Stock
There is an upward development for Launch Tech Co Ltd compared to yesterday, with an increase of €0.020 (2.680%).
Pros and Cons of Launch Tech Co Ltd in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
B****
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Launch Tech Co Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Launch Tech Co Ltd | 2.680% | 0.000% | 1.987% | -42.537% | -18.259% | 234.783% | 78.241% |
| Chongqing Machinery & Electric Co Ltd | 1.020% | -2.000% | -10.909% | 40.000% | -6.667% | 237.931% | 340.449% |
| Jenoptik AG | 0.170% | -11.852% | -21.848% | 83.926% | 82.422% | 21.926% | 23.529% |
| Tennant Co. | 1.640% | 3.467% | -3.182% | 8.531% | 22.205% | - | - |
News
A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
Key Points
- Interested in SpaceX? Here are five stocks we like better.
- SpaceX shares have fallen below their $135 IPO price, erasing over $1 trillion in implied market value amid concerns about
Celcuity Enters Commercial Stage as FDA Approves REVTORPYK for Advanced Breast Cancer
Key Points
- Interested in Celcuity, Inc.? Here are five stocks we like better.
- Celcuity won full FDA approval for gedatolisib, now branded REVTORPYK, in a specific advanced breast cancer
Vera Therapeutics Wins FDA Approval for TRUTAKNA in IgA Nephropathy, Sets Launch
Key Points
- Interested in Vera Therapeutics, Inc.? Here are five stocks we like better.
- Vera Therapeutics won accelerated FDA approval for TRUTAKNA (atacicept-vymj) to treat adults with primary